Magnum Experiment 23B

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 23B, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Apr 16, 2021, Magnum Experiment 23B's average daily return is +0.25%, while the average monthly return is +5.20%. At this rate, an investment would double in approximately 1.1 years.

Historically, 59% of months were positive and 41% were negative. The best month was Nov 2024 with a return of +45.8%, while the worst month was Apr 2022 at -20.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.

On a daily basis, Magnum Experiment 23B closed higher 53% of trading days. The best single day was Jan 2, 2024 with a return of +27.6%, while the worst single day was May 9, 2022 at -9.6%.

Magnum Experiment 23B has an annualized alpha of 54.83%, beta of 1.74, and R² of 0.36 versus S&P 500 Index. Calculated based on daily prices since April 16, 2021.

• This portfolio captured 429.73% of S&P 500 Index gains and 130.49% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.36 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Magnum Experiment 23B has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Magnum Experiment 23B ranks 8 for risk / return — in the bottom 8% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 23B Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

• 1-Year: 0.84
• All Time: 1.39

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 23B compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Magnum Experiment 23B provided a 0.00% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Magnum Experiment 23B. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 23B was 61.99%, occurring on Nov 9, 2022. Recovery took 150 trading sessions.

The current Magnum Experiment 23B drawdown is 32.87%.

The chart below shows the rolling one-month volatility.